Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Gemina Laboratories's Enterprise Value is $1.83 Mil.
Gemina Laboratories's Cash Flow from Operations for the trailing twelve months (TTM) ended in Oct. 2025 was $0.00 Mil. Therefore, Gemina Laboratories's EV-to-OCF for today is 1,825.00.
The historical rank and industry rank for Gemina Laboratories's EV-to-OCF or its related term are showing as below:
GLABF'
s EV-to-OCF Range Over the Past 10 Years
Min: 2538 Med: 0 Max: 2538
Current: 2538
During the past 5 years, the highest EV-to-OCF of Gemina Laboratories was 2538.00. The lowest was 2538.00. And the median was .
GLABF's EV-to-OCF is not ranked
in the Biotechnology industry.
Industry Median: -3.315
vs GLABF: 2538.00
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Gemina Laboratories's PE Ratio (TTM) for today is calculated as:
Gemina Laboratories's share price for today is $0.05.
Gemina Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.028.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Gemina Laboratories EV-to-OCF Related Terms
Gemina Laboratories EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Gemina Laboratories's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Gemina Laboratories's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gemina Laboratories EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Gemina Laboratories's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Gemina Laboratories's EV-to-OCF falls into.
Gemina Laboratories's current Enterprise Value is $1.83 Mil.
Gemina Laboratories's Cash Flow from Operations for the trailing twelve months (TTM) ended in Oct. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gemina Laboratories (GLABF) has a EV-to-OCF of 1,825.00 as of Jul. 24, 2026. Over the past decade, Gemina Laboratories' EV-to-OCF has ranged from 2,538.00 to 2,538.00.
Is Gemina Laboratories' EV-to-OCF too high?
Gemina Laboratories' current EV-to-OCF is 1,825.00. Over the past 10 years, this metric has ranged from a low of 2,538.00 to a high of 2,538.00.
How does Gemina Laboratories' EV-to-OCF compare to VRTX and REGN?
Gemina Laboratories' EV-to-OCF of 1,825.00 can be compared against companies in the Biotechnology industry. Historically, Gemina Laboratories' own EV-to-OCF has ranged from 2,538.00 to 2,538.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. Gemina Laboratories's current EV-to-OCF is 1,825.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gemina Laboratories stock overvalued right now?
Gemina Laboratories (GLABF) has a current EV-to-OCF of 1,825.00. The current EV-to-OCF is 1,825.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Gemina Laboratories (GLABF), the current EV-to-OCF is 1,825.00 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GLABF has been successfully added to your 
